Quick answer: HLA-B27 testing identifies an inherited immune-system marker that can support evaluation for spondyloarthritis when symptoms or imaging raise suspicion. A positive result is not a diagnosis, and a negative result does not exclude the disorder. Molecular and antigen-based methods differ. QXL must confirm the actual assay and specimen requirements before arranging a Bengaluru collection.
Also known as: HLA B27 antigen, HLA B27 PCR
What is the HLA-B27 test used for?#
- Inflammatory back-pain or sacroiliitis evaluation directed by a clinician.
- Selected cases of recurrent anterior uveitis or other features suggesting spondyloarthritis.
- Clarification of an established clinical differential rather than general population screening.
Conditions it helps investigate: Spondyloarthritis
What does the test measure?#
- HLA-B27: An HLA class I marker associated with several forms of spondyloarthritis; presence is susceptibility, not a diagnosis.
How is it tested?#
General principles: molecular methods such as PCR identify HLA-B*27 alleles; flow cytometry detects cell-surface antigen. These are not identical assays. QXL must confirm whether it offers molecular genotyping, antigen typing or a reflex pathway, including relevant assay limitations.
Sample and preparation#
Specimen: Whole blood is generally used; anticoagulant and minimum volume depend on molecular versus cell-based testing. QXL must supply assay-specific collection instructions.
- Provide symptoms, family history, imaging findings and previous HLA results.
- No fasting is usually required for the marker itself.
- Report a history of stem-cell transplantation or recent transfusion to the ordering clinician and laboratory.
- Use the approved tube and transport procedure; a generic serum tube must not be assumed suitable.
| Specimen detail | What to confirm |
|---|---|
| Volume | Pending QXL assay/SOP confirmation. |
| Container | Pending QXL assay/SOP confirmation; use the approved collection kit. |
| Stability | Pending QXL validated time/temperature and transport instructions. |
| Rejection | QXL to confirm assay-specific rejection rules; identifier mismatch, unsuitable container or compromised sample requires laboratory review. |
How are the results interpreted?#
- A detected marker can support a clinical diagnosis when compatible symptoms or imaging are present.
- Many people carrying HLA-B27 never develop associated disease.
- A negative result does not exclude spondyloarthritis; clinical assessment remains necessary.
Reference interval: Use the QXL report’s assay-specific units, reference interval or decision limit. Age, sex, pregnancy, sampling time and clinical context may change interpretation; there is no universal range for this page.
What are the limitations?#
- Not a standalone diagnosis or a measure of current inflammation or disease severity.
- The predictive value depends on symptoms, family history and population background.
- Rare alleles, cross-reactivity or technical limits differ by method.
- Not a general prenatal prediction test for ankylosing spondylitis.
How does it compare with other tests?#
- HLA-B27 identifies inherited susceptibility; CRP/ESR assess nonspecific inflammation. Neither replaces clinical or imaging assessment.
Notes for referring clinicians#
Provide the diagnostic question, prior results and relevant treatment. Confirm the exact assay, specimen SOP and performing laboratory. Discuss results that conflict with the clinical picture before changing management.
Price, report time and home collection#
- Price: Price requires QXL approval; no unverified price is offered.
- Report time: QXL test-specific turnaround pending confirmation; do not infer from another laboratory.
- Home collection: QXL to confirm test-specific eligibility, collection setting and transport before booking. Ask QXL whether eligible home collection in your Bengaluru pincode is free; do not assume every specimen can be collected at home.
- Processing: QXL to confirm in-house versus referral processing and assay/platform.
- Report review: Proposed reviewer assignment only. Medical review, operations verification and sign-off are pending.
Call +91 9964 639 639 or WhatsApp QXL to confirm the current quote, preparation and collection slot.
Frequently asked questions#
What does HLA-B27 positive mean?#
The tested marker was detected. It increases suspicion in an appropriate clinical setting, but many healthy carriers do not develop spondyloarthritis.
Can I have spondyloarthritis with a negative result?#
Yes. HLA-B27 is one piece of evidence; diagnosis may rely on symptoms, examination, imaging and other findings.
Is HLA-B27 the same as rheumatoid factor?#
No. HLA-B27 is an inherited HLA marker. Rheumatoid factor is an antibody test used in a different clinical assessment.
Is PCR the same as flow cytometry?#
PCR examines genetic material, whereas flow cytometry detects antigen on cells. QXL must identify the actual method on the order and report.
Do I need to fast?#
Fasting is usually not needed for HLA-B27 alone. Follow instructions for any additional blood tests.
Can the result monitor my treatment?#
The inherited marker is not a routine treatment-response measurement. Your clinician uses symptoms, examination and other disease measures.
Should everyone with back pain take this test?#
No. It is most useful when clinical features suggest spondyloarthritis. Testing without a focused question can be misleading.
Why does the laboratory need my clinical history?#
History helps assess the result and select the correct assay. Transplantation and other relevant procedures can also affect the testing context.
Related test guides#
Sources#
- Clinical principles are supported by the cited textbook sections and current primary guidance; actual QXL kit, specimen volume, stability, price, turnaround and availability remain unverified.
Educational information only; not a diagnosis or a substitute for a doctor’s advice.
Medical & Laboratory Disclaimer
Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.
Dr. Ajitha Pillai
MD (Microbiology), Senior Consultant Microbiologist
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

